Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Genome sequencing in pregnancy with normal ultrasound to see if more information helps families

Official title: guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing

Run by Columbia University · NCT07610590 · Data updated 2026-11-12

This study tests whether genome sequencing during pregnancy can provide useful information for families when ultrasounds look normal.

More Prenatal Diagnosis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1042 (estimated)
SponsorColumbia University
Academic / other
Locations3 sites (Boston, Massachusetts and 2 other locations)
StatusRecruiting
StartedApril 29, 2026
Main results expectedJuly 31, 2029
Study endsJuly 31, 2029
Registry record updatedJuly 15, 2026
Trial IDNCT07610590 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnancies without major fetal anomalies planning CVS or amniocentesis and cared for with a certified genetic counselor.

Probably not a fit

Pregnancies with major fetal anomalies or families unwilling to participate in 1 year of follow-up may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter study observes how prenatal whole genome sequencing performs in pregnancies without fetal structural anomalies. It compares sequencing results to standard prenatal testing to understand what additional variants might be found and how these findings could affect clinical care. The study also explores how parents decide what genetic information to receive and how it impacts their pregnancy experience, with follow-up through one year after birth. Researchers will examine the frequency of pathogenic or uncertain variants and the psychosocial needs of parents. Participants include pregnancies undergoing CVS or amniocentesis with eligible criteria and involve certified genetic counselors in care.

Why it matters

Potential benefit: If successful, routine prenatal genome sequencing could provide actionable genetic information that guides care and decision-making for families.

How similar studies have gone: Prior prenatal sequencing studies have shown potential to identify additional genetic information in select cases, but this approach remains investigational in normal-appearing pregnancies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient planned chorionic villus sampling (CVS) or amniocentesis in the absence of major fetal structural anomalies (minor anomalies are eligible, the HPO (Human Phenotype Ontology) will not be used by the analyst)
* Certified genetic counselor involved in care

Exclusion Criteria:

* A major structural anomaly
* Maternal or paternal age less than 18 years old
* Parental unwillingness to participate in 1 year of postnatal follow-up
* Language barrier (non-English or Spanish speaking)

Where it's running

  • Columbia University Irving Medical Center (CUIMC)
    New York, New York, United States
    Recruiting
  • Boston Childrens Hospital
    Boston, Massachusetts, United States
    Active not recruiting
  • New York Genome Center
    New York, New York, United States
    Active not recruiting

Study contacts

  • Principal investigator: Ronald Wapner, MD — Columbia University Irving Medical Center (CUIMC)
  • Study coordinator: Camila Zarate, MPH
  • Email: cz2888@cumc.columbia.edu
  • Phone: 646-300-0197

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.